Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,692
Total Claims
$1.3M
Drug Cost
359
Beneficiaries
$3,500
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+210%
Cost per patient vs peers
$3,500 vs $1,128 avg
+79%
Brand preference vs peers
15.0% vs 8.4% avg
Brand vs Generic
Brand: 2,465 claims · $795K
Generic: 13,936 claims · $456K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 311 | $176K |
| Diclofenac Sodium | 240 | $53K |
| Sitagliptin Phosphate | 75 | $51K |
| Rivaroxaban | 95 | $49K |
| Linaclotide | 58 | $37K |
| Sacubitril/Valsartan | 41 | $26K |
| Sitagliptin Phos/Metformin Hcl | 32 | $25K |
| Dulaglutide | 36 | $24K |
| Semaglutide | 20 | $22K |
| Dapagliflozin Propanediol | 36 | $21K |
| Linagliptin | 38 | $21K |
| Insulin Detemir | 57 | $19K |
| Fluticasone Propion/Salmeterol | 35 | $17K |
| Methenamine Hippurate | 303 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $15K |
Prescribing Profile
Patient Profile
81
Avg Age
67%
Female
2.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data